Aparna Innaparthy

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIMS/OBJECTIVES Patients with implantable cardioverter defibrillators (ICD) often receive an adjunctive anti-arrhythmic therapy. We propose that an addition of spironolactone will reduce the number of clinically significant ventricular arrhythmias and ICD-related therapies. METHODS AND RESULTS In a multicentre retrospective study, 64 patients with(More)
  • 1